Efalizumab for Moderate to Severe Atopic Dermatitis

Clinical trial NCT00226057 · COMPLETED

Trial details

NCT number: NCT00226057
Sponsor: Oregon Health and Science University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2005-06-01
Primary completion: 2005-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.